ADCT
ADC Therapeutics SA
NYSE: ADCT · HEALTHCARE · BIOTECHNOLOGY
$3.78
+0.27% today
Updated 2026-04-29
Market cap
$480.78M
P/E ratio
—
P/S ratio
5.91x
EPS (TTM)
$-1.12
Dividend yield
—
52W range
$1 – $5
Volume
0.9M
ADC Therapeutics SA (ADCT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-74.94M | $-121.36M | $-121.58M | $-168.73M | $-233.38M | $-138.31M | $-118.69M | $-123.83M | $-141.17M |
| Capital expenditures | $3.16M | $2.47M | $2.15M | $2.81M | $6.38M | $687000.00 | $3.22M | $867000.00 | $264000.00 |
| Depreciation | $341000.00 | $740000.00 | $1.65M | $2.19M | $2.63M | $5.74M | $3.27M | $3.28M | — |
| Stock-based comp | $980000.00 | $469000.00 | $1.12M | $37.59M | $60.48M | $50.64M | $13.49M | $6.57M | $6.91M |
| Free cash flow | $-78.10M | $-123.83M | $-123.73M | $-171.54M | $-239.75M | $-139.00M | $-121.90M | $-124.70M | $-141.44M |
| Investing cash flow | $-3.25M | $-2.51M | $-2.25M | $-2.83M | $-6.67M | $-687000.00 | $-3.22M | $-867000.00 | — |
| Financing cash flow | $197.24M | $-24000.00 | $100.51M | $494.97M | $267.39M | $-897000.00 | $73.88M | $97.05M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |